LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
76 hedge funds and large institutions have $86M invested in La Jolla Pharmaceutical Company in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less call options, than puts
Call options by funds: $378K | Put options by funds: $444K
Holders
76
Holding in Top 10
2
Calls
$378K
Puts
$444K
Top Buyers
| 1 | +$2.62M | |
| 2 | +$1.6M | |
| 3 | +$1.5M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.07M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$985K |
Top Sellers
| 1 | -$4.91M | |
| 2 | -$463K | |
| 3 | -$430K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$358K |
| 5 |
BlackRock
New York
|
-$247K |